MAIA Biotechnology Files 8-K

Ticker: MAIA · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1878313

Sentiment: neutral

Topics: regulatory-filing, 8-k

TL;DR

MAIA Bio filed an 8-K. Check for updates.

AI Summary

On April 1, 2025, MAIA Biotechnology, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and significant occurrences. No specific financial figures or new material events were detailed in the provided excerpt.

Why It Matters

This filing signals that MAIA Biotechnology, Inc. has made a regulatory disclosure, which could contain important updates for investors regarding the company's operations or financial health.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report and does not, in this excerpt, detail any specific negative events or financial distress.

Key Players & Entities

FAQ

What specific "Other Events" are being reported by MAIA Biotechnology, Inc. on April 1, 2025?

The provided excerpt of the 8-K filing does not specify the details of the "Other Events" being reported.

What "Financial Statements and Exhibits" are included in this 8-K filing?

The excerpt indicates that "Financial Statements and Exhibits" are part of the filing, but it does not list or describe them.

What is the principal executive office address for MAIA Biotechnology, Inc.?

The principal executive offices are located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.

What is MAIA Biotechnology, Inc.'s telephone number?

The registrant's telephone number, including area code, is (312) 416-8592.

What is the Commission File Number for MAIA Biotechnology, Inc.?

The Commission File Number for MAIA Biotechnology, Inc. is 001-41455.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding MAIA Biotechnology, Inc. (MAIA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing